Dhamija Rajinder K, Donnan Geoffrey A
National Stroke Research Institute, Austin Hospital, University of Melbourne, Heidelberg, 3081, Australia.
Ann Indian Acad Neurol. 2008 Jan;11(Suppl 1):S12-S23.
There is a need for early recognition, diagnosis, and therapy in patients with acute stroke. The most important therapies are thrombolysis or aspirin in hyperacute ischemic stroke and, for secondary prevention, antiplatelet agents, statins, ACE inhibitors (for lowering blood pressure), warfarin, and carotid endarterectomy or stenting. Imaging technology has a crucial role to play in the diagnosis and treatment of stroke. In recent years, significant advances have been made due to the availability of physiological imaging using a variety of techniques, ranging from computerized tomography (CT) to magnetic resonance imaging (MRI), which enable clinicians to define brain anatomy and physiology in greater detail than ever before.
In this article we discuss the imaging techniques currently available for patients with acute stroke, with an emphasis on the utility of these techniques for diagnosis and refining patient selection for early interventions. This is placed in the context of the needs of developing countries.
Although noncontrast CT (NCCT) remains the most commonly used imaging modality to differentiate between ischemic and hemorrhagic stroke, to identify early CT changes, and to rule out stroke mimics, it is not sensitive enough to identify the infarct core or the mechanism of ischemic stroke. MRI, including magnetic resonance angiography (MRA), is the most useful imaging modality for the evaluation of acute stroke; it provides information about the mechanism as well as the vascular territory of the stroke. MRI also provides complete information about the status of tissue through diffusion-weighted imaging (DWI) and about arterial patency by means of MRA. DWI shows acute lesions within minutes of onset of ischemia, while MRA can evaluate extracranial as well as intracranial vessels Evaluation of the proportion of penumbra infarcted tissue is another issue to be considered when instituting thrombolysis, and its clinical usefulness is being assessed in a number of ongoing trials. Penumbral tissue can be identified by perfusion MRI. CT perfusion (CTP) is an emerging alternative, providing similar information about the penumbra and infarct core. A combined approach of NCCT, CT angiography (CTA), and CTP is now being employed at many centers and is known as multimodal CT imaging (MMCT). MMCT provides information about the pathophysiology of acute stroke which is comparable to that provided by MRI, and the technique has the potential to refine patient selection for thrombolysis.
急性中风患者需要早期识别、诊断和治疗。最重要的治疗方法是在超急性缺血性中风中进行溶栓或使用阿司匹林,而在二级预防中,则使用抗血小板药物、他汀类药物、血管紧张素转换酶抑制剂(用于降低血压)、华法林以及颈动脉内膜切除术或支架置入术。成像技术在中风的诊断和治疗中起着至关重要的作用。近年来,由于使用了从计算机断层扫描(CT)到磁共振成像(MRI)等多种技术的生理成像技术,取得了重大进展,这些技术使临床医生能够比以往更详细地定义脑解剖结构和生理功能。
在本文中,我们讨论了目前可用于急性中风患者的成像技术,重点是这些技术在诊断和优化早期干预患者选择方面的实用性。这是在发展中国家的需求背景下进行探讨的。
尽管非增强CT(NCCT)仍然是区分缺血性和出血性中风、识别早期CT变化以及排除类似中风症状最常用的成像方式,但它在识别梗死核心或缺血性中风机制方面不够敏感。包括磁共振血管造影(MRA)在内的MRI是评估急性中风最有用的成像方式;它提供了有关中风机制以及血管区域的信息。MRI还通过扩散加权成像(DWI)提供有关组织状态的完整信息,并通过MRA提供有关动脉通畅情况的信息。DWI在缺血发作几分钟内就能显示急性病变,而MRA可以评估颅外和颅内血管。在进行溶栓治疗时,评估半暗带梗死组织的比例是另一个需要考虑的问题,目前许多正在进行的试验正在评估其临床实用性。半暗带组织可以通过灌注MRI识别。CT灌注(CTP)是一种新兴的替代方法,可提供有关半暗带和梗死核心的类似信息。许多中心现在正在采用NCCT、CT血管造影(CTA)和CTP的联合方法,即多模态CT成像(MMCT)。MMCT提供的有关急性中风病理生理学的信息与MRI相当,该技术有可能优化溶栓治疗的患者选择。